Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Gordon Research Conference on Notch Signaling in Development, Regeneration & Disease
Broadly neutralizing human monoclonal JC polyomavirus VP1-specific antibodies as candidate therapeutics for progressive multifocal leukoencephalopathy.
Development of a recombinant immunotoxin for the immunotherapy of autoreactive lymphocytes expressing MOG-specific BCRs.
Neuro-Immune Interactions at Barrier Surfaces.
Stride time variability as a marker for higher level of gait control in multiple sclerosis: its association with fear of falling.
Accumulation and therapeutic modulation of 6-sulfo LacNAc(+) dendritic cells in multiple sclerosis.
Preclinical studies of sex differences: a clinical perspective.
Efficacy and Safety of Daclizumab High Yield Process Versus Interferon β 1a in Patients With Relapsing-Remitting Multiple Sclerosis ((DECIDE))
CombiRx for MS not better than monotherapy
Treatment with interferon beta-1b delays conversion to clinically definite and McDonald MS in patients with clinically isolated syndromes.
Dimethyl fumarate-associated lymphopenia: Risk factors and clinical significance.
Association of common mitochondrial DNA variants with multiple sclerosis and systemic lupus erythematosus.
Natalizumab plus interferon beta-1a for relapsing multiple sclerosis.
Patient centered decision making: Use of conjoint analysis to determine risk-benefit trade-offs for preference sensitive treatment choices.
Tizanidine: Can Buy Uk
Daclizumab in active relapsing multiple sclerosis (CHOICE study): a phase 2, randomised, double-blind, placebo-controlled, add-on trial with interferon beta.
Validity of the minimal assessment of cognitive function in multiple sclerosis (MACFIMS) in the Italian population.
Two endogenous retroviral loci appear to contribute to Multiple Sclerosis.
Interferon beta treatment of multiple sclerosis increases serum interleukin-7.
Identification of naturally occurring Fatty acids of the myelin sheath that resolve neuroinflammation.
Oligodendrocyte development and myelination in GFP-transgenic zebrafish.
Myelin in cartilaginous fish.
The nature of genetic susceptibility to multiple sclerosis: constraining the possibilities.
The absence of 25-hydroxyvitamin D3-1α-hydroxylase potentiates the suppression of EAE in mice by ultraviolet light.
Disease-modifying drugs for multiple sclerosis in pregnancy: A systematic review.
Pages
« first
‹ previous
…
77
78
79
80
81
82
83
84
85
…
next ›
last »